Effects of a High-Protein/Moderate-Carbohydrate Diet on Appetite, Gut Peptides, and Endocannabinoids-A Preview Study
Overview
Authors
Affiliations
Favorable effects of a high-protein/moderate-carbohydrate (HP/MCHO) diet after weight loss on body weight management have been shown. To extend these findings, associations between perception of hunger and satiety with endocannabinoids, and with glucagon-like peptide-1 (GLP-1) and polypeptide YY (PYY) were assessed. At approximately 34 months after weight loss, 22 female and 16 male participants (mean age 64.5 ± 5.9 years; body mass index (BMI) 28.9 ± 3.9 kg/m) completed a 48 h respiration chamber study. Participants were fed in energy balance with a HP/MCHO diet with 25%:45%:30% or a moderate-protein/high-carbohydrate (MP/HCHO) diet with 15%:55%:30% of energy from protein:carbohydrate:fat. Endocannabinoids and related compounds, relevant postprandial hormones (GLP-1, PYY), hunger, satiety, and ad libitum food intake were assessed. HP/MCHO versus MP/HCHO reduced hunger perception. The lower decremental area under the curve (dAUC) for hunger in the HP/MCHO diet (-56.6% compared to MP, < 0.05) was associated with the higher AUC for 2-arachidonoylglycerol (2-AG) concentrations ( < 0.05). Hunger was inversely associated with PYY in the HP/MCHO group (r = -0.7, < 0.01). Ad libitum food intake, homeostatic model assessment for insulin resistance (HOMA-IR) and incremental AUCs for gut peptides were not different between conditions. HP/MCHO versus MP/HCHO diet-induced reduction in hunger was present after 34 months weight maintenance in the post-obese state. HP/MCHO diet-induced decrease of hunger is suggested to interact with increased 2-AG and PYY concentrations.
Nikrad N, Hosseini B, Pakmehr A, Tousi A, Mokhtari Ardekani A, Farhangi M BMC Endocr Disord. 2023; 23(1):171.
PMID: 37568117 PMC: 10416415. DOI: 10.1186/s12902-023-01420-4.
Matias I, Belluomo I, Raux P, Vallee M Biomolecules. 2023; 13(2).
PMID: 36830753 PMC: 9953102. DOI: 10.3390/biom13020383.
Role and Mechanism of Gut Microbiota in Human Disease.
Chen Y, Zhou J, Wang L Front Cell Infect Microbiol. 2021; 11:625913.
PMID: 33816335 PMC: 8010197. DOI: 10.3389/fcimb.2021.625913.
Tagliamonte S, Gill C, Kirsty Pourshahidi L, Slevin M, Price R, Ferracane R Eur J Nutr. 2020; 60(4):2203-2215.
PMID: 33104865 PMC: 8137602. DOI: 10.1007/s00394-020-02398-8.
Tischmann L, Drummen M, Joris P, Gatta-Cherifi B, Raben A, Fogelholm M Nutrients. 2020; 12(5).
PMID: 32455987 PMC: 7284520. DOI: 10.3390/nu12051512.